Gyan Barik on Wellumio’s IFAIR Perfusion Technology US Patent Gain
Gyan Barik, Executive Director at Wellumio, reposted from Wellumio on LinkedIn:
”Wellumio is proud to announce the granting of US Patent 12,495,983 B2 by the United States Patent Office for our innovative IFAIR perfusion technology.
This advancement equips clinicians with critical insights for stroke care, such as identifying salvageable brain tissue and guiding urgent treatment decisions.
We extend our deepest gratitude to our IP team for this achievement, marking a strong close to the year.”
Quoting Wellumio‘s post:
”US patent granted!
Thrilled to share the U.S. Patent Office granted US 12,495,983 B2 for our IFAIR perfusion technology.
IFAIR is an ASL-style tagging technique adapted for inhomogeneous magnetic fields.
In plain English, we measure brain blood flow without contrast agents or conventional MRI hardware.
IFAIR is the first ASL-like approach built for Pulsed Gradient-Free Mapping, enabling real-time, repeatable perfusion on a 0.1T device.
With IFAIR, Axana becomes the only portable scanner to deliver both diffusion and contrast-free perfusion at the bedside.
Pairing perfusion with diffusion at the bedside helps doctors answer urgent questions in stroke care, like ‘Is there still brain tissue that can be saved?’ and ‘How quickly should we move the patient for treatment?’
Huge thanks to our IP team. Great way to wrap up the year!”
Stay updated with Hemostasis Today.
-
Oct 21, 2026, 09:13Jarod Horobin: Blood 2026 – Connecting Science and People
-
Oct 21, 2026, 08:35Raeeda Gheewala: VTE in Athletes – Risks Beyond the Playing Field
-
Oct 21, 2026, 08:29Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis
-
Oct 21, 2026, 08:21Pham Quy: Taking Stroke Awareness Beyond Hospitals and Into the Community
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis
-
Oct 21, 2026, 06:55Hunain Shahbaz: Extended Dual Antiplatelet Therapy Beyond 12 Months After Drug-Eluting Stent Implantation
-
Oct 21, 2026, 06:19Dawood Findakly: When Should Anticoagulation Be Held or Resumed?
-
Oct 21, 2026, 03:36Steve Watson: Ligand Epitope Ratios Influence Antagonist Inhibition
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral